Loading clinical trials...
Loading clinical trials...
Hypofractionated Stereotactic Radiation Treatments (SBRT) on Children, Teenagers and Young Adults Malignant Tumors
The purpose of this study is to evaluate the efficacy of hypofractionated stereotactic radiation treatments (SBRT) on children, teenagers and young adults malignant tumors.
SBRT (Stereotactic Body Radiation Therapy) is a radiotherapy treatment which involves the delivery of a single high dose radiation treatment or a few fractionated radiation treatments (usually up to 5). A high potent biological dose of radiation is delivered to the tumor improving the cure rates for the tumor, in a manner previously not achievable by standard conventional radiation therapy. For adult patients, the "Haute Authorité de Santé" (HAS) validates some indications for this treatment which are the followings : * Few primary or secondary brain tumors, which cannot be surgically removed * Spinal tumors * Primary bronchopulmonary tumors T1 T2 N0 M0 and pulmonary metastasis with slow growth and controled primary tumor. For pediatrics patients, no indication is now validated by HAS. Indications validated for adults are rare in pediatrics but not exceptional, and in such cases efficient alternative treatments does not exist. In consequence, and regarding the good results obtained in adult patients, it seems very important to validate the efficacy of this treatment on pediatrics population
Age
1 - 20 years
Sex
ALL
Healthy Volunteers
No
Centre Antoine Lacassagne
Nice, Alpes Maritimes, France
Centre Paul Strauss
Strasbourg, Bas-Rhin, France
Hôpital La Timone
Marseille, Bouches Du Rhône, France
Centre François Baclesse
Caen, Calvados, France
CHU Bordeaux - Hôpital Saint André
Bordeaux, Gironde, France
Centre Claudius Régaud
Toulouse, Haute Garonne, France
Institut de Cancérologie de Montpellier
Montpellier, Hérault, France
Centre Eugène Marquis
Rennes, Ille Et Vilaine, France
CHRU de Tours - Hôpital Bretonneau
Tours, Indre Et Loire, France
Institut de Cancérologie de l'Ouest René Gauducheau
Saint-Herblain, Loire Atlantique, France
Start Date
December 3, 2013
Primary Completion Date
April 3, 2020
Completion Date
October 12, 2021
Last Updated
March 8, 2022
61
ACTUAL participants
SBRT treatment
RADIATION
Lead Sponsor
Centre Leon Berard
NCT07224451
NCT02448992
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01324635